Mutations in the PIK3CA gene or loss of PTEN function are common causes of dysregulation in this pathway in cancer, leading to increased cell survival and proliferation, which contributes to tumor progression and resistance to treatment [23,24]. This evidence concerns the gene PIK3CA and neoplasm.